Stephen H Caldwell
Overview
Explore the profile of Stephen H Caldwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
6379
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riescher-Tuczkiewicz A, Caldwell S, Kamath P, Villa E, Rautou P
JHEP Rep
. 2024 Feb;
6(3):100986.
PMID: 38384669
Background & Aims: Despite several recent international guidelines, no consensus exists on the bleeding risk nor haemostatic parameter thresholds that define the safety of invasive procedures in patients with cirrhosis....
2.
Lonardo A, Bril F, Caldwell S, Eslam M, Fan J, Gish R, et al.
J Hepatol
. 2024 Feb;
80(5):e192-e194.
PMID: 38336589
No abstract available.
3.
Wentworth B, Khot R, Caldwell S
Dig Dis Sci
. 2023 Jun;
68(9):3514-3526.
PMID: 37358638
Primary sclerosing cholangitis (PSC) is notoriously challenging to manage given its heterogeneity with regard to diagnosis, management, and progression. The lack of disease-modifying therapy and variable rate of onset of...
4.
Intagliata N, Rahimi R, Higuera-de-la-Tijera F, Simonetto D, Farias A, Mazo D, et al.
Gastroenterology
. 2023 Jun;
165(3):717-732.
PMID: 37271290
Background & Aims: Hospitalized patients with cirrhosis frequently undergo multiple procedures. The risk of procedural-related bleeding remains unclear, and management is not standardized. We conducted an international, prospective, multicenter study...
5.
Pasta A, Calabrese F, Labanca S, Marenco S, Pieri G, Torres M, et al.
Liver Int
. 2023 May;
43(7):1399-1406.
PMID: 37249027
Background & Aims: Patients with cirrhosis are considered in a haemostatic balance, though weaker than in normal subjects. In these patients, however, the use of pharmacological prophylaxis for venous thromboembolism...
6.
Rautou P, Caldwell S, Villa E
Clin Gastroenterol Hepatol
. 2023 Apr;
21(8):2110-2123.
PMID: 37121529
Much has evolved over the past 25 years regarding our understanding of the coagulopathy of liver disease. Paradoxically, this form of coagulopathy is relatively hypercoagulability despite the common clinical impression...
7.
Dahmus J, Hummer B, Rivas G, Schmitz K, Caldwell S, Argo C, et al.
Dig Dis Sci
. 2023 Jan;
68(6):2695-2703.
PMID: 36692803
Background & Aims: Cardiorespiratory fitness and liver fibrosis are independently associated with poor outcomes in patients with nonalcoholic steatohepatitis (NASH), however, conflicting reports exist about their relationship. We aimed to...
8.
Caldwell S, Intagliata N
J Thromb Haemost
. 2022 Nov;
20(12):2756-2757.
PMID: 36372447
No abstract available.
9.
Wentworth B, Caldwell S
Metab Target Organ Damage
. 2022 Sep;
1(1).
PMID: 36090909
Interpretation of diagnostic and surveillance laboratory results and imaging in liver disease is fraught with misinterpretation and/or uncertainty. Nonalcoholic fatty liver disease (NAFLD) represents an ever-growing proportion of liver disease...
10.
Trauner M, Bowlus C, Gulamhusein A, Hameed B, Caldwell S, Shiffman M, et al.
Clin Gastroenterol Hepatol
. 2022 Aug;
21(6):1552-1560.e2.
PMID: 35934287
Background & Aims: Primary sclerosing cholangitis (PSC) is a major unmet medical need in clinical hepatology. Cilofexor is a nonsteroidal farnesoid X receptor agonist being evaluated for the treatment of...